Atomistry » Chlorine » PDB 5sio-5spk » 5sos
Atomistry »
  Chlorine »
    PDB 5sio-5spk »
      5sos »

Chlorine in PDB 5sos: Pandda Analysis Group Deposition -- Crystal Structure of Sars-Cov-2 NSP3 Macrodomain in Complex with ZINC000559260078

Enzymatic activity of Pandda Analysis Group Deposition -- Crystal Structure of Sars-Cov-2 NSP3 Macrodomain in Complex with ZINC000559260078

All present enzymatic activity of Pandda Analysis Group Deposition -- Crystal Structure of Sars-Cov-2 NSP3 Macrodomain in Complex with ZINC000559260078:
3.4.19.121;

Protein crystallography data

The structure of Pandda Analysis Group Deposition -- Crystal Structure of Sars-Cov-2 NSP3 Macrodomain in Complex with ZINC000559260078, PDB code: 5sos was solved by G.J.Correy, J.S.Fraser, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 39.66 / 1.05
Space group P 43
Cell size a, b, c (Å), α, β, γ (°) 88.681, 88.681, 39.483, 90, 90, 90
R / Rfree (%) 13.4 / 15.1

Chlorine Binding Sites:

The binding sites of Chlorine atom in the Pandda Analysis Group Deposition -- Crystal Structure of Sars-Cov-2 NSP3 Macrodomain in Complex with ZINC000559260078 (pdb code 5sos). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Pandda Analysis Group Deposition -- Crystal Structure of Sars-Cov-2 NSP3 Macrodomain in Complex with ZINC000559260078, PDB code: 5sos:

Chlorine binding site 1 out of 1 in 5sos

Go back to Chlorine Binding Sites List in 5sos
Chlorine binding site 1 out of 1 in the Pandda Analysis Group Deposition -- Crystal Structure of Sars-Cov-2 NSP3 Macrodomain in Complex with ZINC000559260078


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Pandda Analysis Group Deposition -- Crystal Structure of Sars-Cov-2 NSP3 Macrodomain in Complex with ZINC000559260078 within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl201

b:20.2
occ:0.30
 CL14 A:WWS201 0.0 20.2 0.3
O A:HOH427 0.5 10.5 0.7
C13 A:WWS201 1.8 18.0 0.3
O A:HOH347 2.4 13.4 0.7
O A:HOH357 2.7 17.7 0.7
HB1 A:ALA38 2.7 11.3 0.7
C12 A:WWS201 2.7 16.8 0.3
HB1 A:ALA38 2.7 11.3 0.3
C15 A:WWS201 2.8 17.1 0.3
H121 A:WWS201 2.8 20.2 0.3
H151 A:WWS201 2.9 20.5 0.3
H A:SER128 3.0 15.2 0.3
O A:ALA129 3.1 9.4 0.7
H A:SER128 3.1 10.3 0.7
H A:ALA129 3.2 11.5 0.7
HD1 A:PHE132 3.3 18.7 0.3
HB2 A:ALA38 3.3 11.3 0.7
CD1 A:PHE132 3.3 15.6 0.3
CB A:ALA38 3.3 9.5 0.3
O A:HOH464 3.4 10.4 0.7
HB3 A:ALA38 3.4 11.3 0.3
CB A:ALA38 3.4 9.4 0.7
HD1 A:PHE132 3.4 12.4 0.7
HB2 A:ALA38 3.4 11.3 0.3
HB2 A:PHE132 3.4 11.4 0.7
H A:ALA129 3.5 14.7 0.3
N A:ALA129 3.6 9.6 0.7
CD1 A:PHE132 3.6 10.3 0.7
HB2 A:PHE132 3.6 17.4 0.3
N A:SER128 3.6 8.6 0.7
N A:SER128 3.6 12.7 0.3
O A:ALA129 3.7 12.7 0.3
HA A:LEU127 3.7 15.0 0.3
CE1 A:PHE132 3.7 15.8 0.3
O A:LEU126 3.7 10.2 0.7
HB3 A:ALA38 3.7 11.3 0.7
HA A:SER128 3.7 10.7 0.7
CG A:PHE132 3.8 15.3 0.3
HE1 A:PHE132 3.9 18.9 0.3
C A:ALA129 3.9 9.7 0.7
HA A:LEU127 3.9 10.9 0.7
HA A:SER128 3.9 16.0 0.3
N11 A:WWS201 4.0 15.6 0.3
N A:ALA129 4.0 12.3 0.3
CG A:PHE132 4.0 9.1 0.7
O A:LEU126 4.0 13.1 0.3
C A:SER128 4.0 8.9 0.7
C16 A:WWS201 4.0 16.2 0.3
CA A:SER128 4.0 8.9 0.7
CE1 A:PHE132 4.2 10.8 0.7
H A:PHE132 4.2 11.8 0.7
CA A:SER128 4.2 13.3 0.3
CB A:PHE132 4.2 9.5 0.7
CB A:PHE132 4.2 14.5 0.3
CA A:ALA129 4.2 10.2 0.7
HB3 A:ALA129 4.3 13.3 0.7
HE1 A:PHE132 4.3 13.0 0.7
CZ A:PHE132 4.4 15.7 0.3
C A:LEU127 4.4 8.4 0.7
C A:LEU127 4.4 12.3 0.3
CD2 A:PHE132 4.4 15.7 0.3
C A:SER128 4.4 12.8 0.3
C10 A:WWS201 4.5 14.8 0.3
CA A:LEU127 4.5 12.5 0.3
C A:ALA129 4.5 12.5 0.3
H A:PHE132 4.6 15.6 0.3
CA A:LEU127 4.6 9.1 0.7
O A:HOH424 4.7 11.7 0.3
CE2 A:PHE132 4.7 15.7 0.3
CA A:ALA38 4.7 8.4 0.7
HA A:ALA38 4.7 10.1 0.7
CA A:ALA38 4.7 9.6 0.3
CD2 A:PHE132 4.7 9.8 0.7
HB3 A:PHE132 4.8 17.4 0.3
HB3 A:PHE132 4.8 11.4 0.7
HG23 A:VAL49 4.8 10.1 0.3
HA3 A:GLY130 4.8 13.2 0.7
C A:LEU126 4.8 9.2 0.7
H161 A:WWS201 4.8 19.5 0.3
CB A:ALA129 4.8 11.1 0.7
HB3 A:ALA129 4.8 14.1 0.3
CA A:ALA129 4.8 12.2 0.3
HB A:VAL49 4.8 12.5 0.7
HG21 A:VAL49 4.8 10.1 0.3
O A:HOH528 4.8 47.9 0.7
HD23 A:LEU127 4.9 15.4 0.3
O A:SER128 4.9 10.2 0.7
HB2 A:PRO125 4.9 11.1 0.7
N A:GLY130 4.9 10.7 0.7
CZ A:PHE132 4.9 10.6 0.7
HZ A:PHE132 4.9 18.9 0.3
HG23 A:VAL49 4.9 14.7 0.7
N A:PHE132 4.9 9.9 0.7
C A:LEU126 4.9 12.5 0.3
O A:HOH373 5.0 9.7 1.0
O A:HOH413 5.0 10.9 0.7
HG21 A:VAL49 5.0 14.7 0.7
HD2 A:PHE132 5.0 18.8 0.3
HD22 A:LEU127 5.0 15.4 0.3
HB A:VAL49 5.0 10.0 0.3
O A:ALA38 5.0 11.0 0.3

Reference:

S.Gahbauer, G.J.Correy, M.Schuller, M.P.Ferla, Y.U.Doruk, M.Rachman, T.Wu, M.Diolaiti, S.Wang, R.J.Neitz, D.Fearon, D.Radchenko, Y.Moroz, J.J.Irwin, A.R.Renslo, J.C.Taylor, J.E.Gestwicki, F.Von Delft, A.Ashworth, I.Ahel, B.K.Shoichet, J.S.Fraser. Structure-Based Inhibitor Optimization For the NSP3 Macrodomain of Sars-Cov-2. Biorxiv 2022.
ISSN: ISSN 2692-8205
PubMed: 35794891
DOI: 10.1101/2022.06.27.497816
Page generated: Fri Jul 26 17:02:49 2024

Last articles

Zn in 9MJ5
Zn in 9HNW
Zn in 9G0L
Zn in 9FNE
Zn in 9DZN
Zn in 9E0I
Zn in 9D32
Zn in 9DAK
Zn in 8ZXC
Zn in 8ZUF
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy